Working Group Talk "Decoding Lipoprotein(a): From Atherosclerosis to Clinical Implications"

Learning objectives

• Understand the mechanisms by which Lipoprotein(a) contributes to atherosclerosis, coronary artery disease and cardiovascular risk.
• Laboratory Testing & Challenges: Learn about current laboratory protocols, key biomarkers, and the practical hurdles in standardizing Lipoprotein(a) testing.
• Translate Knowledge into Practice: Explore strategies for integrating Lipoprotein(a) testing into clinical workflows and discuss management approaches informed by the latest research and patient perspectives.
• Patient Perspectives: Gain insights into the patient experience and expectations regarding Lipoprotein(a) testing and management.

Programme

Chairs

   
Isabel Goncalves (Lund, Sweden) 

 
Elena Osto (Graz, Austria)

 
Teresa Padro (Barcelona, Spain)

Programme

Lp(a)-associated cardiovascular risk & high-risk populations

 
Edina Cenko (Bologna, Italy)

Lipoprotein(a) in atherosclerosis 

 Simon Kraler (Zurich, Switzerland)

Demystifying tipoprotein(a) testing: bridging the lab bench and the clinic

Sanja Stankovic (Belgrade, Serbia)

Management strategies and emerging therapies 

Giuseppe Danilo Norata (Milan, Italy)

Patient Perspective

Julie Harris (Manchester, UK) - ESC Patient Forum representative 

Q&A and interactive discussion

Questions and Answers

Participants will have the opportunity to interact with the chair and speakers asking their questions verbally using the “Raise hand” feature or in writing using the "Q&A" module. Chairs and speakers can answer directly in the module (publicly or privately) or discuss live during the event.

Registration

Registration for this event is free for everyone.

Register

Registration deadline: 11 June 2025 at 15:00 CET

The event recording will be accessible on demand a couple of weeks after the live event.